Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer.
Kelly CM, Bernard PS, Krishnamurthy S, Wang B, Ebbert MT, Bastien RR, Boucher KM, Young E, Iwamoto T, Pusztai L. Kelly CM, et al. Oncologist. 2012;17(4):492-8. doi: 10.1634/theoncologist.2012-0007. Epub 2012 Mar 14. Oncologist. 2012. PMID: 22418568 Free PMC article.
Review of the clinical studies using the 21-gene assay.
Kelly CM, Warner E, Tsoi DT, Verma S, Pritchard KI. Kelly CM, et al. Oncologist. 2010;15(5):447-56. doi: 10.1634/theoncologist.2009-0277. Epub 2010 Apr 26. Oncologist. 2010. PMID: 20421266 Free PMC article. Review.
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
Bianchini G, Pusztai L, Karn T, Iwamoto T, Rody A, Kelly C, Müller V, Schmidt S, Qi Y, Holtrich U, Becker S, Santarpia L, Fasolo A, Del Conte G, Zambetti M, Sotiriou C, Haibe-Kains B, Symmans WF, Gianni L. Bianchini G, et al. Breast Cancer Res. 2013;15(5):R86. doi: 10.1186/bcr3481. Breast Cancer Res. 2013. PMID: 24060333 Free PMC article.
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
Smyth L, Watson G, Walsh EM, Kelly CM, Keane M, Kennedy MJ, Grogan L, Hennessy BT, O'Reilly S, Coate LE, O'Connor M, Quinn C, Verleger K, Schoeman O, O'Reilly S, Walshe JM. Smyth L, et al. Among authors: kelly cm. Breast Cancer Res Treat. 2015 Oct;153(3):573-82. doi: 10.1007/s10549-015-3555-4. Epub 2015 Sep 12. Breast Cancer Res Treat. 2015. PMID: 26364296
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.
Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J. Sugiu K, et al. Among authors: kelly cm. Acta Med Okayama. 2015;69(5):291-9. doi: 10.18926/AMO/53675. Acta Med Okayama. 2015. PMID: 26490026 Free article. Clinical Trial.
346 results